Literature DB >> 23751349

Protocadherin-7 induces bone metastasis of breast cancer.

Ai-Min Li1, Ai-Xian Tian, Rui-Xue Zhang, Jie Ge, Xuan Sun, Xu-Chen Cao.   

Abstract

Breast cancer had a propensity to metastasize to bone, resulting in serious skeletal complications associated with poor outcome. Previous study showed that Protocadherin-7 (PCDH7) play an important role in brain metastatic breast cancer, however, the role of PCDH7 in bone metastatic breast cancer has never been explored. In the present study, we found that PCDH7 expression was up-regulation in bone metastatic breast cancer tissues by real-time PCR and immunohistochemistry assays. Furthermore, suppression of PCDH7 inhibits breast cancer cell proliferation, migration, and invasion in vitro by MTT, scratch, and transwell assays. Most importantly, overexpression of PCDH7 promotes breast cancer cell proliferation and invasion in vitro, and formation of bone metastasis in vivo. These data provide an important insight into the role of PCDH7 in bone metastasis of breast cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone metastasis; Breast cancer; PCHD7

Mesh:

Substances:

Year:  2013        PMID: 23751349     DOI: 10.1016/j.bbrc.2013.05.131

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Modulation of Mutant KrasG12D -Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function.

Authors:  Xiaorong Zhou; Mahesh S Padanad; Bret M Evers; Bethany Smith; Nicole Novaresi; Shruthy Suresh; James A Richardson; Emily Stein; Jingfei Zhu; Robert E Hammer; Kathryn A O'Donnell
Journal:  Mol Cancer Res       Date:  2018-11-08       Impact factor: 5.852

Review 2.  Beyond E-cadherin: roles of other cadherin superfamily members in cancer.

Authors:  Frans van Roy
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

3.  PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

Authors:  Xiaorong Zhou; Barrett L Updegraff; Yabin Guo; Michael Peyton; Luc Girard; Jill E Larsen; Xian-Jin Xie; Yunyun Zhou; Tae Hyun Hwang; Yang Xie; Jaime Rodriguez-Canales; Pamela Villalobos; Carmen Behrens; Ignacio I Wistuba; John D Minna; Kathryn A O'Donnell
Journal:  Cancer Res       Date:  2016-11-07       Impact factor: 12.701

4.  Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.

Authors:  Ok-Seon Kwon; Haeseung Lee; Hyeon-Joon Kong; Eun-Ji Kwon; Ji Eun Park; Wooin Lee; Seungmin Kang; Mirang Kim; Wankyu Kim; Hyuk-Jin Cha
Journal:  Oncogene       Date:  2020-05-09       Impact factor: 9.867

5.  Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences.

Authors:  Muthana Al Abo; Larisa Gearhart-Serna; Steven Van Laere; Jennifer A Freedman; Steven R Patierno; Eun-Sil Shelley Hwang; Savitri Krishnamurthy; Kevin P Williams; Gayathri R Devi
Journal:  NPJ Breast Cancer       Date:  2022-06-13

Review 6.  Aberrant expression and functions of protocadherins in human malignant tumors.

Authors:  Ming Shan; Yonghui Su; Wenli Kang; Ruixin Gao; Xiaobo Li; Guoqiang Zhang
Journal:  Tumour Biol       Date:  2016-07-24

7.  Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.

Authors:  Mingfei Xu; Chaoyue Liu; Lulan Pu; Jinrong Lai; Jingjia Li; Qianwen Ning; Xin Liu; Shishan Deng
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

8.  Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.

Authors:  Emila Kurbasic; Martin Sjöström; Morten Krogh; Elin Folkesson; Dorthe Grabau; Karin Hansson; Lisa Rydén; Sofia Waldemarson; Peter James; Emma Niméus
Journal:  Clin Proteomics       Date:  2015-05-12       Impact factor: 3.988

9.  Expression of tumor necrosis factor-alpha-mediated genes predicts recurrence-free survival in lung cancer.

Authors:  Baohua Wang; Ning Song; Tong Yu; Lianya Zhou; Helin Zhang; Lin Duan; Wenshu He; Yihua Zhu; Yunfei Bai; Miao Zhu
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

10.  The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer.

Authors:  Yuhao Chen; Lu Shen; Bairong Chen; Xiao Han; Yunchi Yu; Xiaosa Yuan; Lou Zhong
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.